Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100040955 | 10004095 | 5 | F | 201401 | 20140327 | 20140312 | 20140331 | EXP | US-JNJFOC-20140305803 | JANSSEN | 87.00 | YR | M | Y | 0.00000 | 20140331 | N | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100040955 | 10004095 | 1 | PS | XARELTO | 1 | ORAL | N | UNKNOWN;UNKNOWN;UNKNOWN | 0 | 15 | MG | TABLET | |||||||
100040955 | 10004095 | 2 | SS | XARELTO | 1 | ORAL | N | UNKNOWN;UNKNOWN;UNKNOWN | 202439 | 15 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
100040955 | 10004095 | 1 | Cerebrovascular accident prophylaxis |
100040955 | 10004095 | 2 | Atrial fibrillation |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
100040955 | 10004095 | DE |
100040955 | 10004095 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
100040955 | 10004095 | Cerebral haemorrhage | |
100040955 | 10004095 | Cerebrovascular accident | |
100040955 | 10004095 | Death | |
100040955 | 10004095 | Drooling |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
100040955 | 10004095 | 1 | 201401 | 0 | ||
100040955 | 10004095 | 2 | 201401 | 0 |